ARCHIVES

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

This article is from The Cancer Letter archive.

Vol. 20 No. 36 | September 23, 1994

Download PDF Visit The Full Archive

Related Articles

Nutrition, Disease Oriented Contracts

December 4, 1981

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993

Mammography Screening Effective In Women Under 50: BCDDP

September 25, 1987

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012